share_log

【持股变动报告】股东报告减持Cyfuse Biomedical K.K.(4892.JP)股份至11.11%

Insider decrases its stake in Cyfuse Biomedical KK(4892.JP) to 11.11%

Futu News ·  Sep 11 14:32

On Sep 11, SBI Ventures Two株式会社 and related parties submitted the Change Report to Ministry of Finance. The report shows that SBI Ventures Two株式会社 and related parties decreased their holdings in $Cyfuse Biomedical KK (4892.JP)$, with their joint shareholding ratio down from 11.35% to 11.11%.

JPStockInsiderTradingAutoNewsSpider_nn_S100UCVK_1726036320_en-us

Source: Edinet Announcement

What is the 5% shareholding reporting system?

Shareholders with holding ratio exceeding 5% must submit a Large Shareholding Report within five business days from that day. If the holding ratio increases or decreases by 1% or more after submitting a Large Shareholding Report, the holder must submit a Change Report within five business days from that day.

The translation is provided by third-party software.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment